Yewle Jivan, Wattamwar Paritosh, Tao Zhimin, Ostertag Eric M, Ghoroghchian P Peter
Vindico Pharmaceuticals, Inc., A169 ASTeCC Bldg., Lexington, Kentucky, 40506, USA.
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 76-261F, Cambridge, Massachusetts, 02139, USA.
Pharm Res. 2016 Mar;33(3):573-89. doi: 10.1007/s11095-015-1809-9. Epub 2015 Oct 27.
To develop a technique that maximizes the encapsulation of functional proteins within neutrally charged, fully PEGylated and nanoscale polymer vesicles (i.e., polymersomes).
Three conventional vesicle formation methods were utilized for encapsulation of myoglobin (Mb) in polymersomes of varying size, PEG length, and membrane thickness. Mb concentrations were monitored by UV-Vis spectroscopy, inductively coupled plasma optical emission spectroscopy (ICP-OES) and by the bicinchoninic acid (BCA) assay. Suspensions were subject to protease treatment to differentiate the amounts of surface-associated vs. encapsulated Mb. Polymersome sizes and morphologies were monitored by dynamic light scattering (DLS) and by cryogenic transmission electron microscopy (cryo-TEM), respectively. Binding and release of oxygen were measured using a Hemeox analyzer.
Using the established "thin-film rehydration" and "direct hydration" methods, Mb was found to be largely surface-associated with negligible aqueous encapsulation within polymersome suspensions. Through iterative optimization, a novel "progressive saturation" technique was developed that greatly increased the final concentrations of Mb (from < 0.5 to > 2.0 mg/mL in solution), the final weight ratio of Mb-to-polymer that could be reproducibly obtained (from < 1 to > 4 w/w% Mb/polymer), as well as the overall efficiency of Mb encapsulation (from < 5 to > 90%). Stable vesicle morphologies were verified by cryo-TEM; the suspensions also displayed no signs of aggregate formation for > 2 weeks as assessed by DLS. "Progressive saturation" was further utilized for the encapsulation of a variety of other proteins, ranging in size from 17 to 450 kDa.
Compared to established vesicle formation methods, "progressive saturation" increases the quantities of functional proteins that may be encapsulated in nanoscale polymersomes.
开发一种技术,使功能蛋白在中性电荷、完全聚乙二醇化的纳米级聚合物囊泡(即聚合物囊泡)中实现最大程度的包封。
采用三种传统的囊泡形成方法,将肌红蛋白(Mb)包封在不同大小、聚乙二醇长度和膜厚度的聚合物囊泡中。通过紫外-可见光谱、电感耦合等离子体发射光谱(ICP-OES)和二辛可宁酸(BCA)测定法监测Mb浓度。对悬浮液进行蛋白酶处理,以区分表面结合的Mb与包封的Mb的量。分别通过动态光散射(DLS)和低温透射电子显微镜(cryo-TEM)监测聚合物囊泡的大小和形态。使用血红素氧分析仪测量氧气的结合和释放。
使用已建立的“薄膜复水”和“直接复水”方法时,发现Mb在聚合物囊泡悬浮液中主要与表面结合,而水相包封可忽略不计。通过反复优化,开发了一种新颖的“逐步饱和”技术,该技术大大提高了Mb的最终浓度(溶液中从<0.5提高到>2.0 mg/mL)、可重复获得的Mb与聚合物的最终重量比(从<1提高到>4 w/w% Mb/聚合物)以及Mb包封的整体效率(从<5提高到>90%)。通过cryo-TEM验证了稳定的囊泡形态;通过DLS评估,悬浮液在>2周内也未显示出聚集形成的迹象。“逐步饱和”进一步用于包封各种其他蛋白质,其大小范围为17至450 kDa。
与已建立的囊泡形成方法相比,“逐步饱和”增加了可包封在纳米级聚合物囊泡中的功能蛋白的量。